Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial
Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedKey update: page now warns about potential delays due to funding lapses and confirms the NIH Clinical Center is open, plus a version upgrade to v3.2.0.SummaryDifference2%

- Check33 days agoChange DetectedAdds multiple contact emails and phone numbers and updates the revision from v3.0.2 to v3.1.0; core content and key identifiers are unchanged beyond the version bump.SummaryDifference0.0%

- Check47 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' navigation link was removed, a minor UI change with no impact on core content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding Milan and Padua in Italy, while removing previous location terms and related topics. Additionally, the revision number has been updated to v3.0.0.SummaryDifference2%

- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.